Cyient Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints

June 25, 2026
Posted by: Kunal Singla
Category: News

Cyient Q1 Results FY27: Uniresearch projects Revenue Rs 1,979 Cr | PAT Rs 245 Cr (21-analyst consensus). Q4 FY26: Rev Rs 1,927 Cr | PAT Rs 66 Cr.

The Cyient outlook is anchored on verified Q4 FY26 actuals and Uniresearch analysis applying the 21-analyst FY27 consensus to Q1 FY26 actuals: Revenue Rs 1,979 Cr (+15.6% YoY) and PAT Rs 245 Cr (+56.2% YoY). Prepared by Ankit Jaiswal.

Click Here – Get Free Investment Predictions

Table of Contents

Cyient – Uniresearch Prediction

Metric	Q1 FY26 Actual	Q1 FY27 Uniresearch Prediction	YoY Change	Source
Cyient Revenue (Rs Cr)	1,712	1,979	+15.6%	Uniresearch \| 21-analyst FY27 consensus
PAT (Rs Cr)	157	245	+56.2%	Uniresearch \| 21-analyst FY27 consensus
Avg Analyst Target	Rs 1,019	12-month view	–	21 analysts

21-analyst FY27 consensus: Rev +15.6%, PAT +56.2%. Not guaranteed outcomes.

Cyient Q4 FY26 Key Metrics

Metric	Q4 FY26 Actual	YoY Change	Source
Revenue (Rs Cr)	1,927	+0.9% YoY	Consolidated quarterly data
PAT (Rs Cr)	66	-64.5% YoY	Consolidated quarterly data

Analyst Views on Cyient

The 21-analyst FY27 consensus projects revenue growth of +15.6% and profit growth of +56.2% for Cyient, with an average 12-month target of Rs 1,019.

Key Watchpoints for Cyient

Revenue Delivery

The Cyient revenue target is Rs 1,979 Cr (+15.6% consensus, Q1 FY26 base Rs 1,712 Cr).

PAT vs Consensus

PAT target Rs 245 Cr (+56.2% vs Q1 FY26 actual Rs 157 Cr). Q4 FY26 PAT was Rs 66 Cr.

Risks to Cyient Prediction

Revenue Shortfall

Revenue below +15.6% consensus would miss the Rs 1,979 Cr target.

PAT Headwinds

Cost pressures or margin contraction could affect PAT vs the +56.2% consensus.

Conclusion: Cyient

Uniresearch predicts Cyient Revenue Rs 1,979 Cr and PAT Rs 245 Cr using the 21-analyst FY27 consensus. Track live updates on Univest.

Track Cyient Live on the Univest Screener

Download the Univest iOS App or Univest Android App for live alerts.

Disclaimer: Revenue and PAT actuals are sourced from consolidated quarterly financial data. Q1 Results FY27 Uniresearch predictions apply analyst consensus growth rates to verified Q1 FY26 actuals. These are projections, not guaranteed outcomes. Investments in securities are subject to market risk. For educational purposes only. SEBI RA INH000013776.

FAQs on Cyient

What is Uniresearch’s PAT prediction for Cyient Q1 Results FY27?

Ans. Uniresearch projects Cyient Q1 FY27 PAT at Rs 245 Cr (+56.2% vs Q1 FY26 base Rs 157 Cr).

What is the Revenue forecast for Cyient Q1 Results FY27?

Ans. Cyient Q1 FY27 Revenue projected at Rs 1,979 Cr (+15.6% vs Q1 FY26 Rs 1,712 Cr).

What were Cyient Q1 Results FY27?

Ans. Q4 FY26: Revenue Rs 1,927 Cr (+0.9% YoY), PAT Rs 66 Cr (-64.5% YoY).

How many analysts cover Cyient Q1 Results FY27?

Ans. The Cyient Q1 Results prediction uses 21-analyst FY27 consensus, avg target Rs 1,019.

What FY27 consensus was used for Cyient Q1 Results FY27?

Ans. Revenue +15.6% and profit +56.2% based on 21-analyst FY27 consensus.

What are risks to Cyient Q1 Results FY27?

Ans. Revenue below +15.6% or PAT below +56.2% consensus are the main risks.

What Q1 FY26 base was used for Cyient Q1 Results FY27?

Ans. Q1 FY26 Revenue Rs 1,712 Cr and PAT Rs 157 Cr.

News Q1 results

Author: Kunal Singla

Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.